Network chips maker MACOM Technology Solutions (NASDAQ: MTSI) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 38.8% year on year to $218.1 million. Guidance for next quarter’s revenue was optimistic at $230 million at the midpoint, 2.1% above analysts’ estimates. Its non-GAAP profit of $0.79 per share was in line with analysts’ consensus estimates.
Huntington Ingalls (NYSE:HII) Reports Sales Below Analyst Estimates In Q4 Earnings, Stock Drops 10.7%
Aerospace and defense company Huntington Ingalls (NYSE:HII) missed Wall Street’s revenue expectations in Q4 CY2024, with sales falling 5.4% year on year to $3.00 billion. Its GAAP profit of $3.15 per share was 10.8% below analysts’ consensus estimates.
Roblox’s (NYSE:RBLX) Q4 Sales Top Estimates But Stock Drops 21.5%
Gaming metaverse operator Roblox (NYSE:RBLX) reported Q4 CY2024 results exceeding the market’s revenue expectations, with sales up 31.8% year on year to $988.2 million. The company expects next quarter’s revenue to be around $1.00 billion, coming in 2.5% above analysts’ estimates. Its GAAP loss of $0.33 per share was 26.2% above analysts’ consensus estimates.
Warner Music Group (NASDAQ:WMG) Posts Q4 Sales In Line With Estimates
Global music entertainment company Warner Music Group (NASDAQ:WMG) met Wall Street’s revenue expectations in Q4 CY2024, but sales fell by 4.7% year on year to $1.67 billion. Its GAAP profit of $0.45 per share was 34% above analysts’ consensus estimates.
Analysis-Trump's aid cuts imperil emerging market investment cash
The United States' decision to freeze and potentially scrap its core aid agency jolted countries receiving its funding and could make it harder for emerging economies to attract private cash, investors said. The U.S. Agency for International Development (USAID) not only disbursed $44 billion in fiscal 2023, but anchors private investment in everything from healthcare to small businesses, and underpins the creditworthiness of bigger emerging markets borrowing money on sovereign debt markets.
IQVIA (NYSE:IQV) Exceeds Q4 Expectations, Stock Soars
Clinical research company IQVIA (NYSE: IQV) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 2.3% year on year to $3.96 billion. On the other hand, the company’s full-year revenue guidance of $15.93 billion at the midpoint came in 0.6% below analysts’ estimates. Its non-GAAP profit of $3.12 per share was in line with analysts’ consensus estimates.
In a weak quarter for brokerages, RXO’s stock price takes a pounding after earnings
RXO’s stock price was pummeled Wednesday after the release of its earnings The post In a weak quarter for brokerages, RXO’s stock price takes a pounding after earnings appeared first on FreightWaves.
Under Armour (NYSE:UAA) Delivers Impressive Q4, Stock Soars
Athletic apparel company Under Armour (NYSE:UAA) reported Q4 CY2024 results beating Wall Street’s revenue expectations, but sales fell by 5.7% year on year to $1.40 billion. Its non-GAAP profit of $0.08 per share was significantly above analysts’ consensus estimates.
5 Things to Know Before the Stock Market Opens
News of the day for Feb. 6, 2025
Philip Morris (NYSE:PM) Surprises With Q4 Sales, Stock Soars
Tobacco company Philip Morris International (NYSE:PM) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 7.3% year on year to $9.71 billion. Its non-GAAP profit of $1.55 per share was 3.4% above analysts’ consensus estimates.